concept

AMYLOID PATHOLOGY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID PATHOLOGY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

80Connections

1Hypotheses

19Analyses

17Outgoing

50Incoming

0Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	AMYLOID PATHOLOGY

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

amyloid-pathology

mechanism · 758 words

→

Pathway Diagram

graph TD
    AMYLOID_PATHOLOGY["AMYLOID PATHOLOGY"]
    AMYLOID_PATHOLOGY -->|"involved_in"| Alzheimer_S_Disease["Alzheimer'S Disease"]
    AMYLOID_PATHOLOGY -.biomarker for.-> Alzheimer_s_Disease["Alzheimer's Disease"]
    AMYLOID_PATHOLOGY -->|"interacts"| Neuroinflammation["Neuroinflammation"]
    AMYLOID_PATHOLOGY -->|"interacts"| mitochondrial_dysfunction["mitochondrial dysfunction"]
    Ptau217["Ptau217"] -.biomarker for.-> AMYLOID_PATHOLOGY
    ABETA42["ABETA42"] -->|"component_of"| AMYLOID_PATHOLOGY
    ABETA40["ABETA40"] -->|"component_of"| AMYLOID_PATHOLOGY
    APOE4["APOE4"] -->|"causes"| AMYLOID_PATHOLOGY
    APOE3["APOE3"] -.protects against.-> AMYLOID_PATHOLOGY
    Oligodendrocytes["Oligodendrocytes"] -->|"interacts"| AMYLOID_PATHOLOGY
    Anti_Amyloid_Immunotherapy["Anti-Amyloid Immunotherapy"] -->|"targets"| AMYLOID_PATHOLOGY

Outgoing (17)

Target	Relation	Type	Str
Alzheimer'S	biomarker_for	disease	0.95
Alzheimer's Disease	drives	disease	0.95
ALZHEIMER'S DISEASE	associated_with	entity	0.90
Alzheimer'S Disease	involved_in	disease	0.90
Alzheimer's Disease	biomarker_for	disease	0.85
Neuroinflammation	interacts_with	process	0.80
Tau Pathology	associated_with	phenotype	0.80
Alzheimer's Disease	contributes_to	disease	0.79
cholinergic vulnerability	causes	phenotype	0.70
neurodegeneration	causes	phenotype	0.70
Alzheimer's disease	risk_factor_for	disease	0.70
mitochondrial dysfunction	interacts_with	process	0.70
microglial metabolic reprogramming	causes	mechanism	0.70
Caspase-3 activation	causes	phenotype	0.70
Caspase-3 activation	regulates	process	0.70
caspase-3 activation	associated_with	phenotype	0.70
PV+ interneuron loss	causes	mechanism	0.50

Incoming (63)

Source	Relation	Type	Str
Ptau217	biomarker_for	biomarker	0.95
ABETA40	component_of	protein	0.95
ABETA42	component_of	protein	0.95
APOE4	upregulates	protein	0.90
Anti-Amyloid Immunotherapy	targets	drug	0.90
APOE3	protects_against	protein	0.90
lecanemab	inhibits	drug	0.90
donanemab	inhibits	drug	0.90
APOE4	causes	protein	0.90
Oligodendrocytes	interacts_with	cell_type	0.90
p-tau217	biomarker_for	gene	0.90
Donanemab	targets	drug	0.90
APOE*ε4 allele	drives	phenotype	0.90
Lecanemab	targets	drug	0.90
NLRP3	associated_with	protein	0.90
Dazucorilant	treats	drug	0.90
Lipopolysaccharide	activates	compound	0.90
35320002	induced by	paper	0.90
Disease-associated microglia	regulates	cell_type	0.85
TIMP3	associated_with	protein	0.85
BDNF	associated_with	protein	0.85
BOK Overexpression	associated_with	mechanism	0.85
Glymphatic Failure	precedes	process	0.85
CD33	involved_in	gene	0.85
Glymphatic System Dysfunction	precedes	process	0.85
J20 Mouse Model	associated_with	cell_type	0.80
5Xfad Mouse Model	associated_with	cell_type	0.80
BDNF	downregulates	protein	0.80
IL4	upregulates	protein	0.80
IL9	upregulates	protein	0.80
Positron Emission Tomography	involved_in	process	0.80
FGF2	upregulates	protein	0.80
Nr3C1 Inhibition	protects_against	mechanism	0.80
IL9	biomarker_for	protein	0.80
FGF2	biomarker_for	protein	0.80
IL4	biomarker_for	protein	0.80
Glucocorticoid Receptor	involved_in	receptor	0.80
Neural Cell Culture Model	associated_with	cell_type	0.80
TREM2	modulates	gene	0.75
Chronic Inflammation	associated_with	process	0.75
Trem2 deletion	prevents	process	0.70
Caspase-1 deletion	reduces	process	0.70
UPR modulation	reduces	process	0.70
P2RX7 deficiency	causes	process	0.70
TREM2 activation	inhibits	process	0.70
TREM2	protective_against	protein	0.70
PPARA AGONISTS	decreases	drug	0.70
Neuroinflammation	interacts_with	process	0.70
HDAC6 inhibition	prevents	drug	0.70
DNA damage	precedes	process	0.70

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate	0.785	-	Do β-amyloid plaques and neurofibrillary

Mentioning Analyses (19)

Scientific analyses that reference this entity

What is the minimum effective dose of trazodone required for disease-modifying e

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.605

Neuroinflammation Biomarker Panel for Early AD Detection

neurodegeneration | 2026-04-18 | 7 hypotheses Top: 0.105

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

neurodegeneration | 2026-04-17 | 0 hypotheses

What amyloid threshold level is required for optimal clinical benefit in early A

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.577

What signals trigger microglia to specifically recognize and phagocytose LC axon

neuroinflammation | 2026-04-14 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

Extended debate: CYP46A1 Overexpression Gene Therapy

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: TREM2 Microglial Activation Rescues Amyloid Clearance in AD

closed · Rounds: 4 · Score: 0.75 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II somatostatin interneurons to restore de

closed · Rounds: 4 · Score: 0.54 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound with real-time gamma feedbac

closed · Rounds: 4 · Score: 0.19 · 2026-04-27

Related Research

Hypotheses and analyses mentioning AMYLOID PATHOLOGY in their description or question text

No additional research found

AMYLOID PATHOLOGY

Understanding Entity Pages

Wiki Pages (1)

amyloid-pathology

Pathway Diagram

Outgoing (17)

Incoming (63)

Targeting Hypotheses (1)

Mentioning Analyses (19)

What is the minimum effective dose of trazodone required for disease-modifying e

Neuroinflammation Biomarker Panel for Early AD Detection

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

What amyloid threshold level is required for optimal clinical benefit in early A

What signals trigger microglia to specifically recognize and phagocytose LC axon

Why have numerous phase 3 clinical trials failed despite advances in understandi

What are the molecular signatures that distinguish protective vs. harmful microg

How can circuit-level neurodegeneration mechanisms be identified without complet

Do P2RX7 antagonists selectively block pathogenic exosomes while preserving bene

What are the optimal temporal windows for TREM2 inhibition vs activation in Alzh

Which specific post-translational modifications create druggable epitopes unique

What determines organelle-specific autophagy selectivity in neurodegenerative di

How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxici

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Circuit-level neural dynamics in neurodegeneration

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Lipid raft composition changes in synaptic neurodegeneration

Test Hypothesis Fixtures

Experiments (0)

Related Papers (0)

Debates (20)

Extended debate: CYP46A1 Overexpression Gene Therapy

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

Debate: TREM2 Microglial Activation Rescues Amyloid Clearance in AD

Debate: Closed-loop tACS targeting EC-II somatostatin interneurons to restore de

Debate: Closed-loop transcranial focused ultrasound with real-time gamma feedbac

Related Research